Abstract:Non-Alcoholic Fatty Liver Disease (NAFLD) has become increasingly common globally, raising serious concerns for public health. NAFLD is a complex and multifaceted disease that includes a range of liver diseases, such as cirrhosis, non-alcoholic steatohepatitis (NASH), and simple hepatic steatosis. A combination of environmental, metabolic, and genetic factors causes it. Recent data suggests that vitamin D, a fat-soluble vitamin with various physiological roles, may be crucial for liver health and the development of NAFLD. This cross-sectional study aimed to investigate vitamin D's potential impact on liver function and the development of NAFLD. A Cross-Sectional Study was conducted at the Department of Medicine, MTI, LRH, Peshawar, from August 2019 to January 2020. Participants for this study were selected from the Department of Medicine at MTI, LRH, Peshawar, between August 2019 and January 2020. The study population included individuals with NAFLD identified by laboratory, radiographic, and clinical criteria. Blood samples were taken to measure the serum levels of vitamin D and liver enzymes, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Additional clinical and demographic information was also collected. The average age of the participants in this study was forty years, and there was an equal distribution of genders. Following treatment, the severity of NAFLD significantly decreased. At the beginning of the study, 12.3% of participants had severe steatosis, 40.3% had moderate, and 48.4% had mild steatosis. After treatment, 40.3% of patients had no steatosis, 47.8% had mild steatosis, and 17% had significant steatosis. ALT, ALP, and bilirubin levels showed significant improvements in liver function, with p-values <0.05. While an increase in ALP indicated improved liver function, decreased ALT levels demonstrated reduced liver inflammation. Lower bilirubin levels indicated improved liver health. These findings suggest that treatment, possibly involving vitamin D supplementation, improved liver function and reduced the severity of NAFLD, highlighting the need for further research. This study indicates that vitamin D supplementation may benefit liver function and non-alcoholic fatty liver disease severity. The findings suggest that vitamin D may be a helpful treatment option for managing NAFLD, calling for further investigation and clinical testing.

Vitamin D ameliorates age-induced nonalcoholic fatty liver disease by increasing the mitochondrial contact site and cristae organizing system (MICOS) 60 level

Vitamin D Receptor Targets Hepatocyte Nuclear Factor 4α and Mediates Protective Effects of Vitamin D in Nonalcoholic Fatty Liver Disease.

Active Vitamin D Supplementation Alleviates Initiation and Progression of Nonalcoholic Fatty Liver Disease by Repressing the P53 Pathway.

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism

Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway

Vitamin D 1,25-Dihydroxyvitamin D 3 reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization

Vitamin D Mitigates Hepatic Fat Accumulation and Inflammation and Increases SIRT1/AMPK Expression in AML-12 Hepatocytes

Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice

Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing

Effects of Vitamin D and Resveratrol on Metabolic Associated Markers in Liver and Adipose Tissue from SAMP8 Mice.

Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice

Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish Model

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update

Meta-analysis: vitamin D and non-alcoholic fatty liver disease

Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis

THE IMPACT OF VITAMIN D ON HEPATIC ENZYMES AND NON-ALCOHOLIC FATTY LIVER DISEASE ACROSS–SECTIONAL STUDY

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease

Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction

Eliciting the Mitochondrial Unfolded Protein Response by Nicotinamide Adenine Dinucleotide Repletion Reverses Fatty Liver Disease in Mice